# PHIO PHARMACEUTICALS CORP (PHIOXXXX)

> Institutional ownership reported to the SEC as of Q4 2019, from Form 13F filings. Source: https://holderbook.com/stocks/PHIOXXXX/

- Reporting holders: 7
- Reported value: $220.0K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [UBS Group AG](https://holderbook.com/funds/1610520-ubs-group-ag/) | $427.0K | 45,409 | 0.0% | 4 |
| [SG Americas Securities, LLC](https://holderbook.com/funds/1313360-sg-americas-securities-llc/) | $135.0K | 792,374 | 0.0% | 5 |
| [RENAISSANCE TECHNOLOGIES LLC](https://holderbook.com/funds/1037389-renaissance-technologies-llc/) | $57.0K | 333,890 | 0.0% | 4 |
| [Virtu Financial LLC](https://holderbook.com/funds/1533964-virtu-financial-llc/) | $17.0K | 96,955 | 0.0% | 1 |
| [VANGUARD GROUP INC](https://holderbook.com/funds/102909-vanguard-group-inc/) | $5.0K | 26,460 | 0.0% | 5 |
| [HSBC HOLDINGS PLC](https://holderbook.com/funds/873630-hsbc-holdings-plc/) | $5.0K | 29,370 | 0.0% | 1 |
| [MORGAN STANLEY](https://holderbook.com/funds/895421-morgan-stanley/) | $1.0K | 4,810 | 0.0% | 5 |
| [Kelly Financial Services LLC](https://holderbook.com/funds/2023336-kelly-financial-services-llc/) | $1 | 5 | 0.0% | 4 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q4 2019 | 7 | $220.0K |
| Q3 2019 | 8 | $259.0K |
| Q2 2019 | 10 | $909.0K |
| Q1 2019 | 12 | $591.0K |
| Q4 2018 | 7 | $647.0K |